Home Optimizing ICSI outcomes in women with PCOS: the influence of BMI, hormonal levels, and male fertility parameters
Article
Licensed
Unlicensed Requires Authentication

Optimizing ICSI outcomes in women with PCOS: the influence of BMI, hormonal levels, and male fertility parameters

  • Muhjah Falah Hassan ORCID logo EMAIL logo , Hind Abdul Kadim , Rabab Zahir Al-Yasiry , Sahbaa Hafedh Sagban , Sulagna Dutta and Pallav Sengupta ORCID logo EMAIL logo
Published/Copyright: September 4, 2024

Abstract

Objectives

Women with PCOS often experience significant difficulties in achieving spontaneous pregnancy. Intracytoplasmic sperm injection (ICSI) is a viable treatment option for these patients, offering an acceptable success rate. This study purposes to identify factors that may positively or negatively influence pregnancy rates in PCOS women undergoing ICSI and explore potential modifications to enhance successful pregnancy outcomes.

Methods

The study included ninety sub-fertile couples with female partners with diagnosed PCOS. Comprehensive evaluations of the partners included medical history, physical examination, hormonal analysis, transvaginal ultrasound (TVUS), and seminal fluid analysis. All couples underwent ICSI. Pregnancy rates were determined by positive pregnancy tests 14 days after fresh embryo transfer, and participants were divided into two groups: pregnant and non-pregnant.

Results

Of the 90 women who underwent ICSI cycles, 24 achieved pregnancies, resulting in a pregnancy rate of 26.66 %. Non-pregnant women had significantly higher body mass indices (BMI). Additionally, women with elevated cycle day 2 serum estradiol (E2) levels and low follicle-stimulating hormone (FSH) levels exhibited significantly lower pregnancy rates. Women whose male partners had abnormal semen parameters also demonstrated significantly lower pregnancy rates.

Conclusions

Several factors negatively impact pregnancy rates in PCOS women undergoing ICSI, including high BMI, elevated E2, low FSH levels on cycle day 2, a lower number of mature oocytes, and male factor sub-fertility. Many of these factors can be mitigated through the use of ICSI, thereby improving the chances of achieving a successful pregnancy.


Corresponding authors: Muhjah Falah Hassan, MBCHB, PhD, Department of Anatomy, Histology and Embryology, College of Medicine, University of Kerbala, Kerbala, Iraq, E-mail: ; and Pallav Sengupta, PhD, Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, UAE, E-mail:

  1. Research ethics: The study followed on obtaining the human ethical clearance from the Medical Research Bioethical Committee of University of Kerbala, College of Medicine (6/26-1-2022).

  2. Informed consent: The investigators have obtained the written consents of participation from the respondents.

  3. Author contributions: MFH, HAK designed and planned the article, MFH, HAK, RZAY, SH performed the experiments, MFH, SD, PS analysed the data, wrote the article, made the final revisions. All the authors have read and approved the manuscript.

  4. Competing interests: The authors declare that they do not have any conflict of interest.

  5. Research funding: None.

  6. Data availability: Data will be available from the investigators.

References

1. Hassan, MF, Sengupta, P, Dutta, S. Assisted reproductive technologies for women with polycystic ovarian syndrome. Biomed Pharmacol J 2021;14:1305–8. https://doi.org/10.13005/bpj/2231.Search in Google Scholar

2. Bhattacharya, K, Saha, I, Sen, D, Bose, C, Chaudhuri, GR, Dutta, S, et al.. Role of anti-mullerian hormone in polycystic ovary syndrome. Middle East Fertil Soc J 2022;27:32. https://doi.org/10.1186/s43043-022-00123-5.Search in Google Scholar

3. Al Safi, WG, Hassan, MF. Pregnancy rate in women with PCOS with high LH/FSH ratio undergoing ICSI. Latin Am J Pharm 2021;40:336–40.Search in Google Scholar

4. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7. https://doi.org/10.1093/humrep/deh098.Search in Google Scholar PubMed

5. Bhattacharya, K, Sengupta, P, Dutta, S, Chaudhuri, P, Das Mukhopadhyay, L, Syamal, AK. Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India. Endocrine 2021;72:86–95. https://doi.org/10.1007/s12020-020-02555-3.Search in Google Scholar PubMed

6. Yasmin, A, Roychoudhury, S, Paul Choudhury, A, Ahmed, AF, Dutta, S, Mottola, F, et al.. Polycystic ovary syndrome: an updated overview foregrounding impacts of ethnicities and geographic variations. Life 2022;12:1974. https://doi.org/10.3390/life12121974.Search in Google Scholar PubMed PubMed Central

7. Sengupta, P, Dutta, S, Hassan, MF. Polycystic ovary syndrome (PCOS) and oxidative stress. J Integ Sci Technol 2024;12:752. https://doi.org/10.62110/sciencein.jist.2024.v12.752.Search in Google Scholar

8. Hassan, M, Al-Yasiry, R, Ghaleb, R. Possible predisposing and predictable factors for the development of ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovary syndrome (PCOS) whom have undergone intra cytoplasmic sperm injection (ICSI). Malay J Biochem Mol Biol 2020;1:37–40.Search in Google Scholar

9. Al-yasiry, RZ, Jwad, MA, Hasan, MF, Alsayigh, HA. How obesity affects female fertility. Med J Babylon 2022;19:111–14. https://doi.org/10.4103/mjbl.mjbl_8_22.Search in Google Scholar

10. Bazarganipour, F, Taghavi, SA, Allan, H, Hosseini, N. Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: a qualitative study. Int J Reprod Biomed 2017;15:553. https://doi.org/10.29252/ijrm.15.9.553.Search in Google Scholar

11. Lebbe, M, Taylor, AE, Visser, JA, Kirkman-Brown, JC, Woodruff, TK, Arlt, W. The steroid metabolome in the isolated ovarian follicle and its response to androgen exposure and antagonism. Endocrinology 2017;158:1474–85. https://doi.org/10.1210/en.2016-1851.Search in Google Scholar PubMed PubMed Central

12. Ambiger, S, Patil, SB, Rekha, M, Dhananjaya, S. Role of leutenising hormone LH and insulin resistance in polycystic ovarian syndrome. Int J Reprod Contracep Obs Gynecol 2017;6:3892–7.10.18203/2320-1770.ijrcog20174029Search in Google Scholar

13. Hashemi, AH, Mozdarani, H, Naghavi, A. Comparison of the levels of LH and FSH, TSH, prolactin, progesterone and estradiol hormones between iranian infertile women with polycystic ovary syndrome and healthy women. Int J Med Res Health Sci 2016;5:370–5.Search in Google Scholar

14. Wissing, M, Bjerge, M, Olesen, A, Hoest, T, Mikkelsen, A. Impact of PCOS on early embryo cleavage kinetics. Reprod Biomed Online 2014;28:508–14. https://doi.org/10.1016/j.rbmo.2013.11.017.Search in Google Scholar PubMed

15. Hassan, MF, Al-yasiry, RZ. How polycystic ovary syndrome (PCOS) affects the fertility potential of reproductive age females. Global J Pub Health Med 2019;1:77–84.10.37557/gjphm.v1i2.21Search in Google Scholar

16. World Health Organization. Examination and processing of human semen, 5th ed. Geneva, Switzerland: World Health Organization; 2010.Search in Google Scholar

17. Granot, I, Dekel, N. Preparation and evaluation of oocytes for intracytoplasmic sperm injection. In: Textbook of assisted reproductive techniques. Boca Raton, Florida: CRC Press; 2023:103–10 pp.10.1201/9781003268598-10Search in Google Scholar

18. Sakkas, D, Gardner, DK. Evaluation of embryo quality analysis of morphology and physiology. In: Textbook of assisted reproductive techniques. Boca Raton, Florida: CRC Press; 2017:225–42 pp.Search in Google Scholar

19. De Leo, V, Musacchio, M, Cappelli, V, Massaro, M, Morgante, G, Petraglia, F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 2016;14:1–17. https://doi.org/10.1186/s12958-016-0173-x.Search in Google Scholar PubMed PubMed Central

20. Abruzzese, GA, Silva, AF, Velazquez, ME, Ferrer, MJ, Motta, AB. Hyperandrogenism and polycystic ovary syndrome: effects in pregnancy and offspring development. WIREs Mech Dis 2022;14:e1558. https://doi.org/10.1002/wsbm.1558.Search in Google Scholar PubMed

21. Qiao, J, Feng, HL. Extra-and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011;17:17–33. https://doi.org/10.1093/humupd/dmq032.Search in Google Scholar PubMed PubMed Central

22. Matsuyama, S, Whiteside, S, Li, S-Y. Implantation and decidualization in PCOS: unraveling the complexities of pregnancy. Int J Mol Sci 2024;25:1203. https://doi.org/10.3390/ijms25021203.Search in Google Scholar PubMed PubMed Central

23. Salvetti, NR, Ortega, HH, Veiga-Lopez, A, Padmanabhan, V. Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep. Biol Reprod 2012;87:21–10. https://doi.org/10.1095/biolreprod.112.100024.Search in Google Scholar PubMed PubMed Central

24. Fancsovits, P, Tóthné, ZG, Murber, Á, Rigó, J, Urbancsek, J. Importance of cytoplasmic granularity of human oocytes in in vitro fertilization treatments. Acta Biol Hungar 2012;63:189–201. https://doi.org/10.1556/abiol.63.2012.2.3.Search in Google Scholar PubMed

25. Hassan, MF, Abdul-Kadim, H, Edan, BJ, Dutta, S, Sengupta, P. Embryo quality and intracytoplasmic sperm injection (ICSI) outcome in Iraqi women with polycystic ovary syndrome (PCOS): a cohort prospective study. Biomed Pharmacol J 2023;16:863–70. https://doi.org/10.13005/bpj/2668.Search in Google Scholar

26. The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462–77. https://doi.org/10.1093/humrep/dem426.Search in Google Scholar PubMed

27. Prasad, S, Kumar, Y, Singhal, M, Sharma, S. Estradiol level on day 2 and day of trigger: a potential predictor of the IVF-ET success. J Obs Gynecol India 2014;64:202–7. https://doi.org/10.1007/s13224-014-0515-6.Search in Google Scholar PubMed PubMed Central

28. Ryazantseva, EM, Misharina, EV, Potin, VV, Tarasova, MA. Role hyperleptinemia, insulin resistance and hyperestrogenemia in the development of ovarian failure in women with obesity. J Obs Womens Dis 2016;65:56–63. https://doi.org/10.17816/jowd65556-63.Search in Google Scholar

29. Anifandis, G, Koutselini, E, Louridas, K, Liakopoulos, V, Leivaditis, K, Mantzavinos, T, et al.. Estradiol and leptin as conditional prognostic IVF markers. Reproduction 2005;129:531–4. https://doi.org/10.1530/rep.1.00567.Search in Google Scholar PubMed

30. Papageorgiou, T, Guibert, J, Goffinet, F, Patrat, C, Fulla, Y, Janssens, Y, et al.. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod 2002;17:2846–50. https://doi.org/10.1093/humrep/17.11.2846.Search in Google Scholar PubMed

31. Doi, SA, Al-Zaid, M, Towers, PA, Scott, CJ, Al-Shoumer, KA. Irregular cycles and steroid hormones in polycystic ovary syndrome. Hum Reprod 2005;20:2402–8. https://doi.org/10.1093/humrep/dei093.Search in Google Scholar PubMed

32. Conway, D, Foulk, R, Gurtcheff, S, Bayles, A, Davis, P, Briton-Jones, C. The effect of high estradiol levels on pregnancy outcomes during in-vitro fertilization. Fertil Steril 2013;100:S489. https://doi.org/10.1016/j.fertnstert.2013.07.337.Search in Google Scholar

33. Abdalla, HI. Debate-assessment of ovarian reserve prior to IVF. Middle East Fertil Soc. J 2007;12:13–26.Search in Google Scholar

34. Eftekhar, M, Rahmani, E, Pourmasumi, S. Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer. Iranian J Reprod Med 2014;12:513.Search in Google Scholar

35. Johnson, S, Schiffner, J, Freundl, G, Bachmann, N, Gnoth, C. Luteinising hormone profiles in conception and non-conception natural cycles. Eur J Contracep Reprod Health Care 2019;24:140–7. https://doi.org/10.1080/13625187.2019.1590697.Search in Google Scholar PubMed

36. Jayakrishnan, K, Nambiar, D, Fency, JL. Comparison of ovarian response between PCOS and non-PCOS patients undergoing ICSI with antagonist protocol. J Infertil Reprod Biol 2015;3:199–207.Search in Google Scholar

37. Xiao, J, Chen, S, Zhang, C, Chang, S. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis. Gynecol Endocrinol 2013;29:187–91. https://doi.org/10.3109/09513590.2012.736561.Search in Google Scholar PubMed

38. Huang, MC, Tzeng, SL, Lee, CI, Chen, HH, Huang, CC, Lee, TH, et al.. GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study. PLoS One 2018;13:e0207081. https://doi.org/10.1371/journal.pone.0207081.Search in Google Scholar PubMed PubMed Central

Received: 2024-07-11
Accepted: 2024-08-20
Published Online: 2024-09-04

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 30.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2024-0035/pdf?lang=en
Scroll to top button